Contraceptive News and Research

RSS

Flu shots may reduce risk of blood clots forming in veins

Flu shots may reduce the risk of blood clots forming in veins by 26 percent, according to research presented at the American Heart Association's Scientific Sessions 2008.

10 Nov 2008

New guidelines for congenital heart disease

These days most children born with congenital heart disease live well into adulthood, thanks to innovative surgical, interventional and medical treatments.

8 Nov 2008

Migraines associated with lower risk of breast cancer

Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Christopher I. Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center report these findings in the November issue of Cancer Epidemiology, Biomarkers and Prevention.

6 Nov 2008

Alcohol advice needs to play a greater role in sex education for teenagers

Alcohol and attitudes are two of the key factors that health professionals need to be aware of when they are dealing with sexually active teenagers.

6 Nov 2008

Watching lots of sexual content on TV linked to subsequent teen pregnancy

Adolescents who have high levels of exposure to television programs that contain sexual content are twice as likely to be involved in a pregnancy over the following three years as their peers who watch few such shows, according to a new RAND Corporation study.

4 Nov 2008

Birth control has long term effect on hormone exposure

Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.

20 Oct 2008

Scouts to 'be prepared' with condoms and trips to sexual health clinics

The Scout Association in Britain will in future offer sex advice to their scouts in an attempt to prepare them for life.

20 Oct 2008

Kill the tobacco industry, or it will keep killing

This month in Rio de Janeiro, the global tobacco industry's annual conference features a special session on what many are seeing as its Armageddon: plain, generic packaging. All packs are identical except for the brand name, printed in standard font. No colours, no logos, no box variations. Nothing but the brand and the health warning.

2 Oct 2008

Review of drug delivery market

Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.

18 Sep 2008

World Vision report finds young brides at risk of contracting HIV/AIDS

A report recently released by World Vision has found that girls in developing countries who marry before age 18 -- whose numbers are expected to double to 100 million in the next 10 years -- are at an increased risk of HIV/AIDS, Reuters reports.

9 Sep 2008

Vaginal rings provide new HIV protection for women

Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Philippine Health Department to promote condom use in fight against HIV/AIDS despite opposition from Catholic Church

Despite opposition from the Roman Catholic Church, the Philippine Department of Health will support the use of condoms to prevent the spread of HIV/AIDS in addition to encouraging education on the topic and promoting measures to guard against sexually transmitted infections, the Philippine Star reports.

2 Sep 2008

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).

27 Aug 2008

HHS releases proposed rule on conscientious objections that would protect providers who refuse to perform abortions

HHS Secretary Mike Leavitt on Thursday announced plans to implement a regulation intended to protect health care providers and other workers from disciplinary measures if they refuse to provide abortions or refer patients to other providers for abortions because of personal, religious or moral reasons, the Washington Post reports.

26 Aug 2008